Literature DB >> 35002239

Targeted PET/MRI Imaging Super Probes: A Critical Review of Opportunities and Challenges.

Anna Kastelik-Hryniewiecka1,2, Pawel Jewula3, Karolina Bakalorz1, Gabriela Kramer-Marek2,4, Nikodem Kuźnik1.   

Abstract

Recently, the demand for hybrid PET/MRI imaging techniques has increased significantly, which has sparked the investigation into new ways to simultaneously track multiple molecular targets and improve the localization and expression of biochemical markers. Multimodal imaging probes have recently emerged as powerful tools for improving the detection sensitivity and accuracy-both important factors in disease diagnosis and treatment; however, only a limited number of bimodal probes have been investigated in preclinical models. Herein, we briefly describe the strengths and limitations of PET and MRI modalities and highlight the need for the development of multimodal molecularly-targeted agents. We have tried to thoroughly summarize data on bimodal probes available on PubMed. Emphasis was placed on their design, safety profiles, pharmacokinetics, and clearance properties. The challenges in PET/MR probe development using a number of illustrative examples are also discussed, along with future research directions for these novel conjugates.
© 2021 Kastelik-Hryniewiecka et al.

Entities:  

Keywords:  bioresponsive probes; clearance; contrast agents; medical imaging; relaxivity; targeting

Mesh:

Year:  2022        PMID: 35002239      PMCID: PMC8733213          DOI: 10.2147/IJN.S336299

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  86 in total

1.  Multimodality PET/MRI agents targeted to activated macrophages.

Authors:  Chuqiao Tu; Thomas S C Ng; Russell E Jacobs; Angelique Y Louie
Journal:  J Biol Inorg Chem       Date:  2013-10-29       Impact factor: 3.358

Review 2.  Recent advances in Gd-chelate based bimodal optical/MRI contrast agents.

Authors:  Peter Verwilst; Soyeon Park; Byungkwon Yoon; Jong Seung Kim
Journal:  Chem Soc Rev       Date:  2015-01-27       Impact factor: 54.564

3.  Next-Generation Magnetic Resonance Imaging Contrast Agents.

Authors:  Janet R Morrow; Éva Tóth
Journal:  Inorg Chem       Date:  2017-06-05       Impact factor: 5.165

4.  Contrast agents for MRI: 30+ years and where are we going?

Authors:  Valérie C Pierre; Matthew J Allen; Peter Caravan
Journal:  J Biol Inorg Chem       Date:  2014-01-11       Impact factor: 3.358

5.  Gadolinium Deposition Disease: A New Risk Management Threat.

Authors:  H Benjamin Harvey; Vrushab Gowda; Glen Cheng
Journal:  J Am Coll Radiol       Date:  2019-11-27       Impact factor: 5.532

6.  In vivo mapping of vascular inflammation using multimodal imaging.

Authors:  Benjamin R Jarrett; Carlos Correa; Kwan Liu Ma; Angelique Y Louie
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

7.  High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.

Authors:  Tomonori Kanda; Kazunari Ishii; Hiroki Kawaguchi; Kazuhiro Kitajima; Daisuke Takenaka
Journal:  Radiology       Date:  2013-12-07       Impact factor: 11.105

8.  Orthogonal synthesis of a heterodimeric ligand for the development of the Gd(III)-Ga(III) ditopic complex as a potential pH-sensitive MRI/PET probe.

Authors:  Nikolay Vologdin; Gabriele A Rolla; Mauro Botta; Lorenzo Tei
Journal:  Org Biomol Chem       Date:  2013-02-13       Impact factor: 3.876

9.  Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo dual-modality PET/MR imaging.

Authors:  Rubel Chakravarty; Hector F Valdovinos; Feng Chen; Christina M Lewis; Paul A Ellison; Haiming Luo; M Elizabeth Meyerand; Robert J Nickles; Weibo Cai
Journal:  Adv Mater       Date:  2014-06-18       Impact factor: 30.849

10.  Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress.

Authors:  Saba Naqvi; Mohammad Samim; Mz Abdin; Farhan Jalees Ahmed; An Maitra; Ck Prashant; Amit K Dinda
Journal:  Int J Nanomedicine       Date:  2010-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.